As the biotech industry relies heavily on data filtering, analysis and sharing, visual technologies become critical for the detection and imaging of biological systems, paving the way for the future of life sciences tools enabling next-generation therapeutics, biomanufacturing & longevity. Our panel of experts delved into these topics and explored a myriad of other critical aspects shaping the future of biotechnology.
Moderator: Dr. Laura Smoliar, the Executive Director of the Taiwan Science & Technology Hub at Stanford University. She is one of our LDV Capital Experts.
Panelists:
- Dr. Elizabeth Neumann, an Assistant Professor at the University of California, Davis. Her lab focuses on understanding the molecular and cellular architecture behind neurological diseases. The research is highly interdisciplinary and involves developing analytical tools and multimodal imaging methods for understanding complex biological phenomena;
- Neil Inala, CEO at Nobias Therapeutics, an AI-first therapeutics company. Nobias is currently running a phase 2 clinical trial for treating symptoms of anxiety, inattention and autism in children with 22q11 deletion syndrome. Neil has been involved with software & systems development for more than 20 years including over 10 years at Google.
- Dr. Olga Troyanskaya, Director at Princeton Precision Health, Professor at Princeton University and Deputy Director for Genomics at the Flatiron Institute of the Simons Foundation.
Links:
About Dr. Laura Smoliar: taiwansthub.stanford.edu/peop...
About Dr. Elizabeth Neumann: chemistry.ucdavis.edu/people/...
Nobias Therapeutics: www.nobiastx.com/
How Visual Tech will Advance Accelerations in Life Sciences & Biotech: www.ldv.co/blog/living-longer...
Visual Technology is Advancing the Discovery & Development of New Materials: www.ldv.co/blog/structuring-a...
How AI is Empowering & Disrupting the Discovery of Proteins, Biologics, Therapeutics & Materials: www.ldv.co/blog/the-age-of-ne...
LDV Capital: www.ldv.co/
LDV Capital invests in people building businesses powered by visual technologies. We thrive on collaborating with deep, technical teams leveraging computer vision, machine learning, and artificial intelligence to analyze visual data. We are the only venture capital firm with this thesis.
Our first annual LDV Vision Summit in 2014 has become known to top technologists, investors, and entrepreneurs as the premier global gathering in visual tech. In 2024, due to the virtual nature of the 10th LDV Vision Summit, it was attended by hundreds of people from at least 30 countries.
Building a business that leverages visual tech/AI? It’s never too early to reach out. We are looking to partner with outliers who are building leapfrog deep tech solutions aimed at improving the world and making all of us a lot of money while we sleep!